Skip to main content

Table 1 Correlation between HXOD-AS1 expression and clinical characteristics of bladder cancer patients

From: Synthetic tetracycline-controllable shRNA targeting long non-coding RNA HOXD-AS1 inhibits the progression of bladder cancer

Parameters Group Total HOXD-AS1 expression P value
    High(n = 30) Low(n = 20)  
Age(years) <60 31 17 14 0.768
  >60 19 12 7  
Gender Male 36 19 17 0.537
  Female 14 9 5  
Tumor size (cm) <3 cm 18 6 12 0.006
  ≥3 cm 32 24 8  
Histological grade Low 22 9 13 0.044
  Hight 28 20 8  
TNM stage I 29 9 20 0.009
  II/III/IV 21 15 6  
Lymphatic metastasis N0 44 29 15 0.650
  N1 or above 6 5 1  
  1. P < 0.05 was considered significant. (Chi-square test was performed)